New synthetic route to (S)-(-)-equol through allylic substitution

Tetrahedron Letters

Volumn 49, Issue 35, 2008, Pages 5156-5158

  Takashima, Yuji ^a   Kobayashi, Yuichi ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALKENE; ALLYL COMPOUND; ALLYLIC PICOLINATE; BROMIDE; COPPER; EQUOL; PICOLINIC ACID;

ARTICLE; BROMINATION; CHIRALITY; DEMETHYLATION; DRUG RESEARCH; DRUG STRUCTURE; DRUG SYNTHESIS; MOLECULAR INTERACTION; STEREOCHEMISTRY; SUBSTITUTION REACTION;

EID: 47049094950     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2008.06.085     Document Type: Article

References (26)

1. Veitch N.C. Nat. Prod. Rep. 24 (2007) 417-464
2. Marais J.P.J., Ferreira D., and Slade D. Phytochemistry 66 (2005) 2145-2176
3. Lamartiniere C.A. Am. J. Clin. Nutr. 71 (2000) 1705S-1707S
4. Adlercreutz H., Mousavi Y., Clark J., Hockerstedt K., Hamalainen E., Wahala K., Makela T., and Hase T. J. Steroid Biochem. Mol. Biol. 41 (1992) 331-337
5. Marrian G.F., and Haslewood G.A.D. Biochem. J. 26 (1932) 1226-1232
6. Chang Y.-C., and Nair M.G. J. Nat. Prod. 58 (1995) 1892-1896
7. Cf. isolation from woods:. Kurosawa K., Ollis W.D., Redman B.T., and Sutherland I.O. J. Chem. Soc., Chem. Commun. (1968) 1263-1294 and 1265-1267
8. Borriello S.P., Setchell K.D., Axelson M., and Lawson A.M. J. Appl. Bacteriol. 58 (1985) 37-43
9. Sathyamoorthy N., and Wang T.T.Y. Eur. J. Cancer 33 (1997) 2384-2389
10. A similar study. Morito K., Hirose T., Kinjo J., Hirakawa T., Okawa M., Nohara T., Ogawa S., Inoue S., Muramatsu M., and Masamune Y. Biol. Pharm. Bull. 24 (2001) 351-356
11. Muthyala R.S., Ju Y.H., Sheng S., Williams L.D., Doerge D.R., Katzenellenbogen B.S., Helferich W.G., and Katzenellenbogen J.A. Bioorg. Med. Chem. 12 (2004) 1559-1567
12. Schmitt E., Dekant W., and Stopper H. Toxicol. In Vitro 15 (2001) 433-439
13. Wang X.-L., Hur H.-G., Lee J.H., Kim K.T., and Kim S.-I. Appl. Environ. Microbiol. 71 (2005) 214-219
14. Heemstra J.M., Kerrigan S.A., Doerge D.R., Helferich W.G., and Boulanger W.A. Org. Lett. 8 (2006) 5441-5443
15. Versteeg M., Bezuidenhoudt B.C.B., Ferreira D., and Swart K.J. J. Chem. Soc., Chem. Commun. (1995) 1317-1318
16. Versteeg M., Bezuidenhoudt B.C.B., and Ferreira D. Tetrahedron 55 (1999) 3365-3376
17. Kiyotsuka Y., Acharya H.P., Katayama Y., Hyodo T., and Kobayashi Y. Org. Lett. 10 (2008) 1719-1722
18. Marco J.A., Carda M., Diaz-Oltra S., Murga J., Falomir E., and Roeper H. J. Org. Chem. 68 (2003) 8577-8582
19. Massad S.K., Hawkins L.D., and Baker D.C. J. Org. Chem. 48 (1983) 5180-5182
20. Bernstein P.R., Snyder D.W., Adams E.J., Krell R.D., Vacek E.P., and Willard A.K. J. Med. Chem. 29 (1986) 2477-2483
21. 3 δ 1.61 ppm for the former and 1.31 ppm for the latter.
22. There still remains a possibility of a few percentage racemization at the aldehyde stage.
23. Pettetier J.D., and Poirier D. Tetrahedron Lett. 35 (1994) 1051-1054
24. 6) δ 31.3 (+), 37.2 (-), 70.2 (+), 102.5 (-), 108.0 (-), 112.6 (+), 115.2 (-), 128.3 (-), 130.1 (-), 131.6 (+), 154.5 (+), 156.1 (+), 156.5 (+).
25. 1H NMR and TLC analyses and by measurement of mp, presently we have no adequate reason for the difference.
26. Synthesis of racemic equol was reported:. Gharpure S.J., Sathiyanarayanan A.M., and Jonnalagadda P. Tetrahedron Lett 49 (2008) 2974-2978